2020
DOI: 10.1016/j.carrev.2019.04.009
|View full text |Cite
|
Sign up to set email alerts
|

Implications of Misclassification of Type 2 Myocardial Infarction on Clinical Outcomes

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

1
21
0
4

Year Published

2020
2020
2023
2023

Publication Types

Select...
5

Relationship

1
4

Authors

Journals

citations
Cited by 20 publications
(26 citation statements)
references
References 18 publications
1
21
0
4
Order By: Relevance
“…Prognosis, in terms of short‐ and longer‐term mortality risks following NSTEMI, has improved in recent years, with fewer deaths after 30 days and more of the deaths that do occur being attributed to non‐CV causes . However, the risk of in‐hospital and post‐discharge mortality following NSTEMI is higher in patients with type 2 NSTEMI than in those with type 1 NSTEMI . This is not surprising and can be explained by the sicker and older age demographic of patients with type 2 NSTEMI compared with those with type 1 NSTEMI …”
Section: Discussionmentioning
confidence: 99%
See 4 more Smart Citations
“…Prognosis, in terms of short‐ and longer‐term mortality risks following NSTEMI, has improved in recent years, with fewer deaths after 30 days and more of the deaths that do occur being attributed to non‐CV causes . However, the risk of in‐hospital and post‐discharge mortality following NSTEMI is higher in patients with type 2 NSTEMI than in those with type 1 NSTEMI . This is not surprising and can be explained by the sicker and older age demographic of patients with type 2 NSTEMI compared with those with type 1 NSTEMI …”
Section: Discussionmentioning
confidence: 99%
“…As a result, current NSTEMI guidelines may be challenging—or in some cases inappropriate—to apply in patients who are experiencing a type 2 NSTEMI, and no formal guidelines for type 2 NSTEMI are available . Studies have found that compared with patients with type 1 NSTEMI, patients with type 2 NSTEMI were less likely to undergo catheterization and revascularization procedures or receive recommended secondary prevention medications at discharge, and they had higher mortality rates . There is therefore a need for evidence‐based diagnosis and management guidelines for NSTEMI that acknowledge the complexities of type 2 MI .…”
Section: Epidemiologymentioning
confidence: 99%
See 3 more Smart Citations